Fortrea Holdings FTRE
NASDAQ FTRE
$20.29 +0.32 (+1.60%)
As of: Sep 17, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Accumulated Expenses came in at $380.8 million in Q2 2026, little changed on a YoY basis from $380.8 million in Q2 2025, and up 6.58% quarter-over-quarter from $357.3 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Accumulated Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Accumulated Expenses for 5 consecutive years, with $380.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses changed 0.0% year-over-year to $380.8 million; the trailing twelve-month figure through Jun 2026 stood at $380.8 million (changed 0.0% YoY), and the FY2025 full-year result was $395.8 million, up 7.03% from the prior year.
  • Accumulated Expenses climbed to $380.8 million in Q2 2026 per FTRE's latest filing, from $357.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $395.8 million in Q4 2025 and bottomed at $322.7 million in Q4 2022.
  • Historically, Accumulated Expenses has averaged $351.9 million across 5 years, with a median of $345.2 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Expenses dropped 3.78% in 2024, then advanced 14.39% in 2025.
  • Over 5 years, Accumulated Expenses stood at $322.7 million in 2022, then grew by 3.97% to $335.5 million in 2023, then gained by 10.22% to $369.8 million in 2024, then increased by 7.03% to $395.8 million in 2025, then declined by 3.79% to $380.8 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $380.8 million, $357.3 million, and $395.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 380.80 Mn
Mar 31, 2026 357.30 Mn
Dec 31, 2025 395.80 Mn
Sep 30, 2025 369.60 Mn
Jun 30, 2025 380.80 Mn
Mar 31, 2025 347.20 Mn
Dec 31, 2024 369.80 Mn
Sep 30, 2024 323.10 Mn
Jun 30, 2024 343.30 Mn
Mar 31, 2024 328.70 Mn
Dec 31, 2023 335.50 Mn
Sep 30, 2023 335.80 Mn
Jun 30, 2023 336.20 Mn
Dec 31, 2022 322.70 Mn